EP Patent

EP0335545A2 — Pharmaceutical formulations for parenteral use

Assigned to University of Florida · Expires 1989-10-04 · 37y expired

What this patent protects

Aqueous parenteral solutions of drugs which are insoluble or only sparingly soluble in water and/or which are unstable in water, combined with a hydroxypropyl,hydroxyethyl, glucosyl, maltosyl or maltotriosyl derivative of beta - or gamma -cyclodextrin, provide a means for allev…

USPTO Abstract

Aqueous parenteral solutions of drugs which are insoluble or only sparingly soluble in water and/or which are unstable in water, combined with a hydroxypropyl,hydroxyethyl, glucosyl, maltosyl or maltotriosyl derivative of beta - or gamma -cyclodextrin, provide a means for alleviating problems associated with drug precipitation at the injection site and/or in the lungs or other organs following parenteral administration.

Drugs covered by this patent

Patent Metadata

Patent number
EP0335545A2
Jurisdiction
EP
Classification
—
Expires
1989-10-04
Drug substance claim
No
Drug product claim
No
Assignee
University of Florida
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.